Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01823315

Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia — GTN-01  

Gestational Trophoblastic Tumor Clinical Trial

Official title:
A Multicenter, Prospective, Randomized Trial of Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia

Clinical Trial Summary

The investigators conducted a trial to determine whether methotrexate or methotrexate/dactinomycin single-course treatment work well as multiple courses of single methotrexate chemotherapy in low-risk gestational trophoblastic neoplasia. It is not yet known whether single-course of chemotherapy is as the same effectiveness as multicourse.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01823315
Study type Interventional
Source Huazhong University of Science and Technology
Contact
Status Active, not recruiting
Phase Phase 3
Start date December 2012
Completion date December 2019
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04562558 - Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia N/A
Completed NCT02096783 - Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer N/A
Completed NCT00293384 - Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant N/A
Completed NCT00003688 - Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia Phase 2
Completed NCT00003107 - Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Phase 1
Recruiting NCT04028479 - The Registry of Oncology Outcomes Associated With Testing and Treatment
Terminated NCT00324324 - Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Phase 3
Recruiting NCT03885388 - Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6 Phase 2/Phase 3
Completed NCT00058071 - Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer Phase 3
Completed NCT00082654 - Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients N/A
Completed NCT00064311 - Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation Phase 1/Phase 2
Completed NCT00897442 - Collecting Tumor Samples From Patients With Gynecological Tumors N/A
Completed NCT00410657 - Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant Phase 2
Terminated NCT00096187 - Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy Phase 2
Completed NCT00010283 - Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Phase 1/Phase 2
Active, not recruiting NCT02834013 - Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Phase 2
Completed NCT00900406 - Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant N/A
Completed NCT00109993 - Campath-1H + FK506 and Methylprednisolone for GVHD Phase 2
Terminated NCT00651716 - T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Terminated NCT00900068 - Blood Samples From Patients on a Clinical Trial to CINV During HSCT N/A